通过使用患者报告的结果来赋予癌症幸存者的权力:一项定量研究
Mary Pat Johnston1, Patricia Friend2
1Mary Pat Johnston.
Oncology nursing forum
|October 22, 2025
概括
患者报告结果 (PROs) 的使用与癌症幸存者的患者赋权 (PE) 有关. 虽然PROs最初促进PE,但在治疗后的三个月内它会下降,这表明需要持续支持.
科学领域:
- 在瘤学瘤学.
- 健康心理学 心理健康心理学
- 护理研究 护理研究
背景情况:
- 早期的幸存者护理在维持患者参与和赋权方面存在挑战.
- 患者报告结果 (PROs) 越来越多地被认为是以患者为中心的护理中的作用.
- 了解影响癌症幸存者的患者赋权 (PE) 的因素对于有效的生存策略至关重要.
研究的目的:
- 调查癌症幸存者在早期生存阶段使用患者报告结果 (PRO) 和患者赋权 (PE) 之间的关联.
- 在这个人群中探索自我效能,症状负担和患者赋权之间的关系.
主要方法:
- 一项定量,重复测量研究,涉及83名癌症幸存者的成年人.
- 通过电子或纸质调查收集的数据包括三个仪器,33名参与者在化疗后立即填写问卷,并在三个月后填写问卷.
- 在社区癌症中心进行便利抽样.
主要成果:
- 在患者赋权和自我效能之间发现了显著的积极关系.
- 在自我有效性和症状严重程度之间观察到显著的负相关性.
- 使用PROs的自我有效性预测了化疗后立即患者的赋权;然而,PE在三个月的随访后下降了.
结论:
- 临床医生驱动的评估对于长期的幸存者护理是不可持续的.
- 使用PRO用于症状和自我有效性评估与增强患者赋权有关.
- 瘤护士在开发和实施幸存者报告的症状评估中发挥着关键作用,以促进癌症幸存者的赋权.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
640
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.8K
相关概念视频
01:21Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
01:24Kaplan-Meier Approach
566
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
566
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:43Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
02:59Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K